Voluntary Termination of PregnancyVECUVGNCT06140069
Voluntary Termination of Pregnancy: Comparison of Women's Experiences Depending on the Method Used.
An observational study of Voluntary Termination of Pregnancy, run by University Hospital, Toulouse.
Trial summary
Voluntary termination of pregnancy (abortion) is a major current societal issue. This is a very common situation, around 225,000 abortions are carried out every year in France. The French law of March 2, 2022 (no. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Voluntary Termination of Pregnancy
- What is being tested?
- Questionnaire
- How many people
- 0 participants
- Where
- No sites listed yet
- Study dates
- 20 Dec 2024to 20 Dec 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- No healthy volunteers
- Adult, Older adult
Study population: Patient coming for Voluntary termination of pregnancy (abortion)
Who may be able to join
- Any adult patient
- Having given her non-opposition after clear and fair information (patient who understands and reads French)
- Patient treated at the Toulouse University Hospital for an abortion between 14 and 16 weeks (dating by ultrasound)
- Singleton pregnancy
- Progressive pregnancy
Who cannot join
- Protected adult patient (guardianship, curatorship, protection of justice)
- Developing psychiatric pathologies
- Fetal anomaly detected
About this study
Official title: Voluntary Termination of Pregnancy Between 14 and 16 Weeks of Amenorrhea: Comparison of Women's Experiences Depending on the Method Used, Surgical or Medicinal.
Voluntary termination of pregnancy (abortion) is a major current societal issue. This is a very common situation, around 225,000 abortions are carried out every year in France. The French law of March 2, 2022 (no. 2022-295) extended the legal deadline for voluntary termination of pregnancy from 14 to 16 weeks of amenorrhea (SA). The recommendations have not been updated following this legal extension, the centers performing abortions are therefore free regarding the protocol for carrying out these so-called late abortions (between 14 and 16 weeks). There are two pregnancy termination techniques practiced in France: medical or surgical. The drug method consists of drug-induced expulsion of the pregnancy. This method is carried out in the delivery room, and lasts several hours. The surgical method consists of an endouterine aspiration carried out in the operating room, which lasts approximately 30 minutes. At the Toulouse University Hospital, as in many centers in France, it is the patient who chooses the method, apart from a contraindication to one or other of these methods. Due to the recent nature of these late abortions, practitioners still have little experience of the consequences of these procedures and this compromises the quality of the information provided to patients. It is necessary to have quality studies to improve knowledge about late abortions, in order to be able to correctly inform patients and allow them to make an informed choice regarding the method used.
- Conditions
- Voluntary Termination of Pregnancy
- Being tested
- Questionnaire
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
QuestionnaireOther
A questionnaire is offered to patients who meet the eligibility criteria and who have given their non-objection during the abortion request consultation.
This questionnaire includes questions for screening for anxiety and depressive disorders.
| Study group | Role | What they receive |
|---|---|---|
| Experimental: Patient treated at the Toulouse University Hospital for an abortion | Patient treated at the Toulouse University Hospital for an abortion between 14 and 16 weeks (dating by ultrasound) presenting with a single and evolving pregnancy. Receives: Other: Questionnaire |
What is being measured
The primary outcome is the main question the study is designed to answer.
Evaluation of anxiety or depressive disorder depending on the method used, surgical or medicinal
Anxiety will be measured using Hospital Anxiety and Depression Scale (HADS)
Measured: At the inclusion visit before abortion and 3 weeks after abortion
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Nov 2023
- Study start20 Dec 2024
- Primary completion20 Dec 2024
- Study completion20 Dec 2024
Why it stopped: too few patients undergoing medical abortion (\< 5 per year)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Voluntary Termination of PregnancyStudies of the same condition, open and under way.
- More trials run by University Hospital, ToulouseThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Toulouse
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Lola LOUSSERT CHAMBRE, MD, Principal investigator, University Hospital, Toulouse
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06140069
- Sponsor's protocol ID
- RC31/23/0563
- Acronym
- VECUVG
- Status last verified
- Jul 2026
- First submitted
- 10 Nov 2023
- Last updated
- 21 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 21 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Voluntary Termination of Pregnancy Between 14 and 16 Weeks of Amenorrhea: Comparison of Women's Experiences Depending on the Method Used, Surgical or Medicinal.
- ClinicalTrials.gov ID
- NCT06140069
- Acronym / sponsor ID
- VECUVG / RC31/23/0563
- Conditions
- Voluntary Termination of Pregnancy
- Study type
- Observational
- Recruitment status
- WithdrawnReason stopped: too few patients undergoing medical abortion (\< 5 per year)
- Enrolment
- 0 participants (actual)
- Lead sponsor
- University Hospital, ToulouseUniversity, hospital or other
- Study start
- 20 Dec 2024 (actual)
- Primary completion
- 20 Dec 2024 (actual)
- Study completion
- 20 Dec 2024 (actual)
- First posted
- 18 Nov 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Voluntary termination of pregnancy (abortion) is a major current societal issue. This is a very common situation, around 225,000 abortions are carried out every year in France. The French law of March 2, 2022 (no. 2022-295) extended the legal deadline for voluntary termination of pregnancy from 14 to 16 weeks of amenorrhea (SA). The recommendations have not been updated following this legal extension, the centers performing abortions are therefore free regarding the protocol for carrying out these so-called late abortions (between 14 and 16 weeks). There are two pregnancy termination techniques practiced in France: medical or surgical. The drug method consists of drug-induced expulsion of the pregnancy. This method is carried out in the delivery room, and lasts several hours. The surgical method consists of an endouterine aspiration carried out in the operating room, which lasts approximately 30 minutes. At the Toulouse University Hospital, as in many centers in France, it is the patient who chooses the method, apart from a contraindication to one or other of these methods. Due to the recent nature of these late abortions, practitioners still have little experience of the consequences of these procedures and this compromises the quality of the information provided to patients. It is necessary to have quality studies to improve knowledge about late abortions, in order to be able to correctly inform patients and allow them to make an informed choice regarding the method used.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Experimental: Patient treated at the Toulouse University Hospital for an abortion | – | Other: QuestionnairePatient treated at the Toulouse University Hospital for an abortion between 14 and 16 weeks (dating by ultrasound) presenting with a single and evolving pregnancy. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patient coming for Voluntary termination of pregnancy (abortion)
Key inclusion criteria (5 listed)
- Any adult patient
- Having given her non-opposition after clear and fair information (patient who understands and reads French)
- Patient treated at the Toulouse University Hospital for an abortion between 14 and 16 weeks (dating by ultrasound)
- Singleton pregnancy
- Progressive pregnancy
Key exclusion criteria (3 listed)
- Protected adult patient (guardianship, curatorship, protection of justice)
- Developing psychiatric pathologies
- Fetal anomaly detected
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| QuestionnaireA questionnaire is offered to patients who meet the eligibility criteria and who have given their non-objection during the abortion request consultation. This questionnaire includes questions for screening for anxiety and depressive disorders. | Other | Experimental: Patient treated at the Toulouse University Hospital for an abortion |
Primary outcome
Evaluation of anxiety or depressive disorder depending on the method used, surgical or medicinal
Time frame: At the inclusion visit before abortion and 3 weeks after abortion
Anxiety will be measured using Hospital Anxiety and Depression Scale (HADS)
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Jul 2026.
- Individual participant dataSharing planned: No
Related trials for Voluntary Termination of Pregnancy
Active, not recruitingObservational study
Requests for Voluntary Termination and Medical Termination of Pregnancy for Maternal, Psychological or Social Reasons At the Women's Center ( La Maison Des Femmes) in Saint-Denis :
Pregnancy, Violence Against Women (VAW)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Lola LOUSSERT CHAMBRE, MD principal investigator
University Hospital, Toulouse
Questions about this trial
What is this clinical trial studying?
An observational study of Voluntary Termination of Pregnancy, run by University Hospital, Toulouse.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 21 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Evaluation of anxiety or depressive disorder depending on the method used, surgical or medicinal (time frame: At the inclusion visit before abortion and 3 weeks after abortion). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2026; AzTrials last refreshed its copy on 8 Nov 2026.